Aurinia Pharmaceuticals Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Aurinia Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2024 was -13.5 %, a 25.3% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Return On Equity for 2023 was -20.1 %, a 21% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Return On Equity for 2022 was -25.4 %, a 48% increase from 2021.
  • Aurinia Pharmaceuticals Inc. annual Return On Equity for 2021 was -48.9 %, a 61.3% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -20.1 +5.34 +21% Jan 1, 2023 Dec 31, 2023
2022 -25.4 +23.5 +48% Jan 1, 2022 Dec 31, 2022
2021 -48.9 -18.6 -61.3% Jan 1, 2021 Dec 31, 2021
2020 -30.3 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.